Ophthalmic Business News

In the eighth part of a 12-part series, Peter J. Polack, MD, FACS, explains his first website conversion tactic.

During a volatile market environment like we are in today or the steep market pullback at the onset of the pandemic in 2020, many investors, including physicians, feel a powerful drive to act in response.

The first patient has been enrolled in a study of the Technolas Teneo excimer laser for LASIK surgery in patients with hyperopia with astigmatism, according to a press release.

Iveric Bio has entered into debt financing for up to $250 million with Hercules Capital and Silicon Valley Bank, according to a press release.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Allison W. Shuren, JD, MSN.

Avista Therapeutics and Roche will partner to develop adeno-associated virus gene therapy vectors for ocular diseases, according to a press release.

ForSight Robotics raised $55 million in a Series A round to advance its fully robotic cataract surgery platform, according to a press release.

The first patient has been dosed in a phase 2 clinical trial investigating MCO-010 ambient light activatable optogenetic monotherapy for Stargardt disease, according to a press release from Nanoscope Therapeutics.

In the seventh part of a 12-part series, Peter J. Polack, MD, FACS, discusses the top five features to include on a website to increase conversion.

The first patient has been enrolled in a phase 2 clinical study evaluating YP-P10 for the treatment of dry eye disease, according to a press release from Yuyu Pharma.